13F-HR filed by Tetragon Partners GP Ltd
Tetragon Partners GP Ltd filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-13, with 39 holding rows worth $635,063,221.
- Accession
- 0000919574-26-005024
- Filer
- CIK 1515070
- Filed
- 2026-08-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2026
A holdings report, 43 entries on the cover page, a total value of $635,063,221 stated on the cover page (in dollars after the unit check, H1), rows summing to $635,063,221 with VALUE read as dollars as filed, 13F file number 028-15287. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerTetragon Partners L.P.028-15282
- included managerTetragon Partners UK LLP028-15285
- included managerTetragon Partners US LP028-15284
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| UIPATH INC | 90364P105 | CL A | 30,950,000 | $336,426,500 | dollars as filed | |
| KOLIBRI GLOBAL ENERGY INC | 50043K406 | COMMON STOCK | 6,834,504 | $33,845,142 | dollars as filed | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 9,500,000 | $15,200,000 | dollars as filed | |
| LYFT INC | 55087P104 | CL A COM | 1,000,000 | $14,610,000 | dollars as filed | |
| DEFINIUM THERAPEUTICS INC | 24477V105 | COM SHS | 286,990 | $13,500,010 | dollars as filed | |
| WORKIVA INC COM CL A | 98139A105 | Stock | 250,000 | $12,127,500 | dollars as filed | |
| SPRINKLR INC | 85208T107 | CL A | 2,200,000 | $11,352,000 | dollars as filed | |
| MBX BIOSCIENCES INC COM | 55287L101 | Stock | 203,543 | $11,235,574 | dollars as filed | |
| ALKAMI TECHNOLOGY INC | 01644J108 | COM | 600,284 | $10,877,146 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 290,441 | $10,807,310 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 570,311 | $10,670,519 | dollars as filed | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 130,484 | $10,635,751 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 295,627 | $10,222,782 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 189,979 | $9,953,950 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 255,934 | $9,861,137 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 35,000 | $8,566,950 | dollars as filed | call |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 764,256 | $8,391,531 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 356,657 | $7,921,352 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 97,173 | $7,704,847 | dollars as filed | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 205,579 | $7,629,037 | dollars as filed | |
| HARMONY BIOSCIENCES HLDGS IN | 413197104 | COM | 201,036 | $7,319,721 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 19,668 | $7,310,006 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 1,242,455 | $7,094,418 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 64,110 | $6,707,188 | dollars as filed | |
| WARNER BROS DISCOVERY INC COM SER A | 934423104 | Stock | 250,000 | $6,665,000 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268306 | COMMON STOCK | 86,996 | $6,073,191 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 297,926 | $5,350,751 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 167,875 | $4,247,238 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 100,000 | $3,339,000 | dollars as filed | call |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 300,000 | $3,294,000 | dollars as filed | call |
| CUE BIOPHARMA INC | 22978P205 | COM | 93,819 | $2,960,928 | dollars as filed | |
| SNOWFLAKE INC COM SHS | 833445109 | Stock | 10,000 | $2,545,000 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576U205 | COMMON STOCK | 250,300 | $2,445,431 | dollars as filed | call |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 400,000 | $2,116,000 | dollars as filed | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 50,000 | $1,855,500 | dollars as filed | call |
| TECTONIC THERAPEUTIC INC | 878972108 | COMMON STOCK | 46,516 | $1,598,988 | dollars as filed | |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 56,052 | $1,356,458 | dollars as filed | |
| TENAX THERAPEUTICS INC | 88032L605 | COM NEW | 75,100 | $1,092,705 | dollars as filed | call |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 8,500 | $152,660 | dollars as filed | call |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000919574-26-005024 | this filing | 2026-08-13 | acceptance time not in the bulk data set |